Industry

LYT-300 achieved systemic blood levels approximately nine-fold greater compared to previous reports with oral allopregnanolone.1 Allopregnanolone is a neurosteroid with proven efficacy that is currently only approved as a 60-hour intravenous infusion. LYT-300, an orally administered prodrug of allopregnanolone, is designed to be differentiated from synthetic analogs, which may not replicate the full target engagement … [Read more…]

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model OXFORD, England–(BUSINESS WIRE)–Beckley Psytech Limited, a private company dedicated to addressing neurological and psychiatric disorders through … [Read more…]

No treatment effect observed in this patient population; substantial improvement in 6-minute walk test seen in both placebo and active groups Study adds to growing body of data supporting strong safety and tolerability profile of LYT-100 (deupirfenidone) Company will drive LYT-100 forward in other indications, with a focus on IPF where human clinical efficacy has … [Read more…]

U.S. News & World Report’s annual hospital survey again ranks Children’s Hospital Los Angeles among the top 10 pediatric hospitals in the nation LOS ANGELES–(BUSINESS WIRE)–#childrenshealth–Children’s Hospital Los Angeles (CHLA) continues its streak of being California’s top hospital for pediatric care and specialty services, according to U.S. News & World Report’s 2022-23 Best Children’s Hospitals … [Read more…]

– First and Only FDA-approved Treatment Demonstrating Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – AMVUTTRA Met Primary and All Secondary Endpoints, with Significant Improvement in Polyneuropathy, Quality of Life and Gait Speed Relative to External Placebo – – Company Expects to Launch in Early July, with Value-Based Agreements to … [Read more…]

OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #RKLY–Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the U.S. market opens on June 27, 2022, according … [Read more…]

Funds Raised Will Support Mental Health Services for Pittsburgh’s LGBTQ+ Community PITTSBURGH–(BUSINESS WIRE)–Persad Center is hosting “Art for Change 2022” on Friday, September 9 at Stage AE on the North Shore. The event, Persad’s 35th Annual, is one of the region’s most significant art auctions. Proceeds support Persad Center’s mission of providing mental health services … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) today announced that it will donate an office building in Downtown Louisville to the University of Louisville (UofL) in support of the activities of UofL’s Health Equity Innovation Hub. The 8-story building, located at 515 W. Market Street, was recently vacated by Humana and contains approximately 130,000 square feet … [Read more…]

NEW YORK–(BUSINESS WIRE)–Accolade Health, Inc. (“Accolade”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that on June 8, 2022 the Compensation Committee of Accolade’s Board of Directors approved the grant of inducement restricted stock unit awards covering 992,382 Class A shares of Accolade’s common stock to 29 new … [Read more…]

LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. … [Read more…]